Knight Therapeutics | GUD - 股本和储备

股票价格

7.50

每天变化

0.05 0.67%

每月一次

1.21%

每年

22.35%

Q2 预测

7.39

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 754.73M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	股本和储备	更改		日
Acasti Pharma	USD 62.82M		732K	2025-09
Akebia Therapeutics	USD 32.61M		8.98M	2025-12
Alaunos Therapeutics	USD 2.15M		650K	2025-12
Aurora Cannabis	CAD 536.36M		30.74M	2025-12
Avita Medical	AUD -16.65M		3.76M	2025-12
Canopy Growth	CAD 758.17M		22.16M	2025-12
Cronos Group	USD 1.09B		11.39M	2025-12
Dianthus Therapeutics	USD 493.4M		53.05M	2025-12
Ionis Pharmaceuticals	USD 491.41M		2.32M	2026-03
IQVIA Holdings	USD 6.5B		343M	2025-12
Knight Therapeutics	CAD 767.27M		480K	2025-12
Moderna	USD 8.65B		680M	2025-12
Omeros	USD -228.68M		15.13M	2025-06
Organigram Holdings	CAD 369.46M		20.33M	2025-12
Organon & Co	USD 752M		154M	2025-12
Revvity	USD 7.38B		180.27M	2025-09
Tectonic Therapeutic	USD 251.33M		16.2M	2025-12
Tilray	USD 1.58B		39.08M	2025-09
Viatris	USD 15.22B		352.9M	2025-09
Xeris Pharmaceuticals	USD 13.69M		14.55M	2025-12